Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Cystatin C-Based Equation Does Not Accurately Estimate the Glomerular Filtration in Japanese Living Kidney Donors.

Tsujimura K, Ota M, Chinen K, Adachi T, Nagayama K, Oroku M, Nishihira M, Shiohira Y, Iseki K, Ishida H, Tanabe K.

Ann Transplant. 2017 Jun 23;22:378-383.

2.

Supplementary Administration of Everolimus Reduces Cardiac Systolic Function in Kidney Transplant Recipients.

Tsujimura K, Ota M, Chinen K, Nagayama K, Oroku M, Nishihira M, Shiohira Y, Abe M, Iseki K, Ishida H, Tanabe K.

Ann Transplant. 2017 May 26;22:315-322.

3.

Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis.

Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y.

PLoS One. 2016 Aug 18;11(8):e0160225. doi: 10.1371/journal.pone.0160225. eCollection 2016.

4.

Riociguat for the treatment of pulmonary arterial hypertension.

Ghofrani HA, Galiè N, Grimminger F, Grünig E, Humbert M, Jing ZC, Keogh AM, Langleben D, Kilama MO, Fritsch A, Neuser D, Rubin LJ; PATENT-1 Study Group.

N Engl J Med. 2013 Jul 25;369(4):330-40. doi: 10.1056/NEJMoa1209655.

5.

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators.

N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.

6.

Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial.

Iseki K, Arima H, Kohagura K, Komiya I, Ueda S, Tokuyama K, Shiohira Y, Uehara H, Toma S; Olmesartan Clinical Trial in Okinawan Patients Under OKIDS (OCTOPUS) Group.

Nephrol Dial Transplant. 2013 Jun;28(6):1579-89. doi: 10.1093/ndt/gfs590. Epub 2013 Jan 25.

PMID:
23355629
7.

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy.

Mori S, Ueki Y, Akeda Y, Hirakata N, Oribe M, Shiohira Y, Hidaka T, Oishi K.

Ann Rheum Dis. 2013 Aug;72(8):1362-6. doi: 10.1136/annrheumdis-2012-202658. Epub 2013 Jan 23.

8.

Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.

Fukagawa M, Komaba H, Onishi Y, Fukuhara S, Akizawa T, Kurokawa K; MBD-5D Study Group.

Am J Nephrol. 2011;33(5):427-37. doi: 10.1159/000327654. Epub 2011 Apr 21.

9.

Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study.

Takeuchi T, Miyasaka N, Inoue K, Abe T, Koike T; RISING study.

Mod Rheumatol. 2009;19(5):478-87. doi: 10.1007/s10165-009-0195-8. Epub 2009 Jul 22.

10.

Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

Akizawa T, Asano Y, Morita S, Wakita T, Onishi Y, Fukuhara S, Gejyo F, Matsuo S, Yorioka N, Kurokawa K; CAP-KD Study Group.

Am J Kidney Dis. 2009 Sep;54(3):459-67. doi: 10.1053/j.ajkd.2009.05.011. Epub 2009 Jul 17. Erratum in: Am J Kidney Dis. 2010 Mar;55(3):616.

PMID:
19615804
11.

Olmesartan clinical trial in Okinawan patients under OKIDS (OCTOPUS) study: design and methods.

Iseki K, Tokuyama K, Shiohira Y, Higa A, Hirano H, Toma S, Kohagura K, Ueda S.

Clin Exp Nephrol. 2009 Apr;13(2):145-51. doi: 10.1007/s10157-008-0116-8. Epub 2008 Dec 20.

PMID:
19101780
12.

Effect of high fiber density ratio polysulfone dialyzer on protein removal.

Tomo T, Matsuyama M, Nakata T, Kadota J, Toma S, Koga N, Fukui H, Arizono K, Takamiya T, Matsuyama K, Ueyama S, Shiohira Y, Uezu Y, Higa A.

Blood Purif. 2008;26(4):347-53. doi: 10.1159/000133430. Epub 2008 May 19.

PMID:
18487878
13.

[Pasteurella multocida meningitis: zoonosis by pets].

Yonaha T, Kouchi M, Kuwae N, Higa A, Uezu Y, Kuniyoshi K, Shiohira Y.

Nihon Naika Gakkai Zasshi. 2007 Aug 10;96(8):1715-6. Japanese. No abstract available.

PMID:
17802726
14.
15.

Early estimation of high peritoneal permeability can predict poor prognosis for technique survival in patients on peritoneal dialysis.

Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, Kumon S, Watanabe S, Shiohira Y, Ishii T, Kawahara T, Suzuki H.

Adv Perit Dial. 2006;22:11-7.

PMID:
16983931
16.

Metabolic syndrome and chronic kidney disease in Okinawa, Japan.

Tanaka H, Shiohira Y, Uezu Y, Higa A, Iseki K.

Kidney Int. 2006 Jan;69(2):369-74.

17.

Outcome study of renal biopsy patients in Okinawa, Japan.

Iseki K, Miyasato F, Uehara H, Tokuyama K, Toma S, Nishime K, Yoshi S, Shiohira Y, Oura T, Tozawa M, Fukiyama K.

Kidney Int. 2004 Sep;66(3):914-9.

18.

Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD.

Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, Kumon S, Watanabe S, Shiohira Y, Ishii T, Kawahara T, Tsuzaki K, Suzuki H.

Am J Kidney Dis. 2002 Nov;40(5):1045-54.

PMID:
12407651
19.

Low serum albumin in elderly continuous ambulatory peritoneal dialysis patients is attributable to high permeability of peritoneum.

Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, Kumon S, Watanabe S, Shiohira Y, Ishii T, Kawahara T, Suzuki H.

Adv Perit Dial. 2001;17:238-43.

PMID:
11510284
20.

Drug-associated cholelithiasis: a case of sulindac stone formation and the incorporation of sulindac metabolites into the gallstones.

Tokumine F, Sunagawa T, Shiohira Y, Nakamoto T, Miyazato F, Muto Y.

Am J Gastroenterol. 1999 Aug;94(8):2285-8.

PMID:
10445564

Supplemental Content

Loading ...
Support Center